Related Experiment Video
Updated: Aug 11, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells
Carolyn Lee1, Jung-Sik Kim, Todd Waldman
1Department of Oncology and Tumor Biology Training Program, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, District of Columbia 20057, USA.
Abstract:
Following DNA damage, human cells arrest primarily in the G(1) and G(2) phases of the cell cycle. Here, we show that after irradiation, human cancer cells with targeted deletion of PTEN or naturally occurring PTEN mutations can exert G(1) and G(2) arrests but are unable to arrest in size. Pharmacological inhibition of phosphoinositol-3-kinase or mTOR in PTEN(-/-) cells restored the size arrest, whereas siRNA-mediated depletion of TSC2 in PTEN(+/+) cells attenuated the size arrest. Radiation treatment potentiated Akt activation in PTEN(-/-) but not PTEN(+/+) cells. Finally, abrogation of the size arrest via PTEN deletion conferred radiosensitivity both in vitro and in vivo. These results identify a new tumor suppressor gene-regulated, DNA damage-inducible arrest that occurs simultaneously with the G(1) and G(2) arrests but is genetically separable from them. We suggest that aberrant regulation of cell size during cell cycle arrest may be important in human cancer pathogenesis.
Insights
Human cancer cells lacking PTEN cannot arrest cell size after DNA damage, leading to increased radiosensitivity. Restoring size arrest via inhibiting PI3K/mTOR pathways can re-sensitize these cells to radiation.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Human cells typically arrest in G1 and G2 phases after DNA damage.
- PTEN is a critical tumor suppressor gene involved in cell growth and survival pathways.
Purpose of the Study:
- To investigate the role of PTEN in DNA damage-induced cell cycle and size arrest.
- To determine the impact of PTEN loss on radiosensitivity.
- To explore therapeutic strategies targeting cell size regulation in PTEN-deficient cancers.
Main Methods:
- Irradiation of human cancer cells with PTEN deletion or mutations.
- Pharmacological inhibition of phosphoinositol-3-kinase (PI3K) and mTOR.
- siRNA-mediated depletion of TSC2.
- Assessment of cell cycle progression, cell size, Akt activation, and radiosensitivity (in vitro and in vivo).
Main Results:
- PTEN-deficient cells arrest in G1/G2 but not in size after irradiation.
- Inhibition of PI3K/mTOR restored size arrest in PTEN(-/-) cells.
- TSC2 depletion attenuated size arrest in PTEN(+/+) cells.
- Radiation potentiated Akt activation in PTEN(-/-) cells.
- Loss of PTEN and abrogation of size arrest conferred radiosensitivity.
Conclusions:
- PTEN regulates a DNA damage-inducible cell size arrest, genetically separable from G1/G2 arrests.
- Aberrant cell size regulation in PTEN-deficient cancers contributes to radiosensitivity.
- Targeting cell size regulation may offer therapeutic benefits for PTEN-mutant cancers.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Replicative Cell Senescence
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle

